Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)
China flag China · Delayed Price · Currency is CNY
25.29
+0.34 (1.36%)
May 8, 2026, 3:00 PM CST

SHA:688393 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,3662,2171,6202,3362,0532,844
Market Cap Growth
-14.13%36.86%-30.68%13.78%-27.80%-17.60%
Enterprise Value
2,0451,9401,4982,2071,7342,081
Last Close Price
25.2923.6917.2524.6621.6029.54
PE Ratio
--76.0758.3348.1035.65
PS Ratio
6.736.443.444.704.056.48
PB Ratio
2.041.911.321.891.682.35
P/TBV Ratio
2.111.931.321.901.722.43
P/FCF Ratio
-131.43----
P/OCF Ratio
136.7055.39457.11136.46211.3447.71
EV/Sales Ratio
5.825.633.184.443.424.74
EV/EBITDA Ratio
--44.4848.2532.2227.63
EV/EBIT Ratio
---292.6380.7235.40
EV/FCF Ratio
-328.66115.00----
Debt / Equity Ratio
0.000.000.010.020.020.01
Debt / EBITDA Ratio
2.22-0.300.580.430.16
Debt / FCF Ratio
-0.18----
Net Debt / Equity Ratio
-0.26-0.23-0.11-0.07-0.20-0.52
Net Debt / EBITDA Ratio
-268.1719.43-4.16-2.01-4.49-8.29
Net Debt / FCF Ratio
47.82-15.576.974.453.877.46
Asset Turnover
0.270.260.340.360.370.33
Inventory Turnover
1.331.442.002.352.883.01
Quick Ratio
7.615.374.713.354.467.99
Current Ratio
9.437.348.195.145.218.51
Return on Equity (ROE)
-3.39%-4.25%1.21%1.71%2.41%6.33%
Return on Assets (ROA)
-1.96%-2.57%-0.21%0.34%0.97%2.77%
Return on Invested Capital (ROIC)
-4.63%-5.49%-0.41%0.71%2.74%10.85%
Return on Capital Employed (ROCE)
-3.40%-4.50%-0.40%0.60%1.70%4.70%
Earnings Yield
-1.60%-2.12%1.31%1.71%2.08%2.80%
FCF Yield
-0.26%0.76%-1.24%-0.88%-3.04%-2.94%
Dividend Yield
0.40%-0.58%0.61%0.65%0.91%
Payout Ratio
--68.14%33.62%62.34%33.00%
Buyback Yield / Dilution
-0.53%-1.59%2.94%-0.53%-1.09%-20.71%
Total Shareholder Return
-0.13%-1.59%3.52%0.08%-0.44%-19.80%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.